CEO Summary: One week after one of the worst storms ever to strike a hospital in the U.S., St. John’s Regional Medical Center in Joplin, Missouri, was back treating patients. Surprisingly, the hospital’s lab was one of the first departments to get up and running again. Within hours of the storm, the lab staff was
Tag: electronic patient record
CEO SUMMARY: There were plenty of headlines about the passage of HITECH last February because of how it expanded funding for electronic medical records. But lesser known are new requirements that providers, including labs and pathology groups, must now take specific compliance actions in response to breaches involving protected health information (PHI). Enforcement of these
A transfusion of the wrong type of blood may have contributed to the death of a critically ill woman at Sarasota Memorial Hospital in Sarasota, Florida last month. The patient died about a day after the transfusion. Following the blood transfusion, a reaction had been observed. Attending physicians do not know if the transfusion of
As predicted in the last issue of THE DARK REPORT, Quest Diagnostics Incorporated did acquire all the remaining shares of MedPlus, Inc. which it didn’t already own. MedPlus offers a variety of clinical information products, including one to create and manage electronic patient records.
KEN FREEMAN JOINS BOARD AT TRW
Kenneth W. Freeman, Chairman and CEO of
This time the Clinical Laboratory Management Association (CLMA) looked in its own backyard to find a Executive Director. On Monday, February 12, Robert Neri will begin his responsibilities at CLMA. Not only does Neri have a long career in laboratory management, but he lives in the Philadelphia area, near CLMA’s offices in Malvern, Pennsylvania. CLMA’s
ONE SIGNIFICANT business strategy in play at Quest Diagnostics Incorporated is venture capital investing.
With $3 billion in sales, Quest Diagnostics is the largest clinical laboratory company in the United States. It understands that the traditional lab sales strategy of marketing to physicians’ offices can no longer support the company’s needs for sustained, rapid growth.
CEO SUMMARY: Two of the country’s largest Pap screen testing organizations are preparing to introduce automated primary screening into their laboratories. NeoPath’s con- tracts with SmithKline Beecham Clinical Laboratories and Kaiser Permanente mark the beginning of a new market cycle. NeoPath is poised to exploit these developments while continuing to enhance AutoPap’s capabilities.
TWO OF HEALTHCARE’S